Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-01-24
2006-01-24
Qazi, Sabiha (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S182000, C552S642000, C552S644000, C552S645000, C552S649000, C424S001110
Reexamination Certificate
active
06989378
ABSTRACT:
The invention is the novel androgen (7α,17β)-7-methyl-17-[(1-oxoundecyl)oxy]estr-4en-3one (MENT undecanoate). This compound distinguishes favourably from other testosterone derivatives in that it has a good solubility in oily media. It particularly exhibits a good dissolved potency relative to testosterone. The compound is particularly suitable for administration by means of injection.
REFERENCES:
patent: 5342834 (1994-08-01), Bardin et al.
Kamischke et al, Intramuscular Testosterone Undecanoate and Norethisterone Enanthate in a Clinical Trial for Male Contraception, The Journal of Clinical Endocrinology & Metabolism, vol. 86, No. 1, 303-309, 2000.
Kamischke et al, An Effective Hormonal Male Contraceptive Using Testosterone Undecanoate with Oral or Injectable Norethisterene Preperations, J Clin Endocrinol Metab 87(2): 530-539, 2002.
Abstract of Grimes et al, Steroid Hormones For Contraception in Men, Cochrane Database Syst Rev. 2004; (3): CD004316.
Chaudry, M., et al: “Hansch analysis of the anabolic activities of some nandrolone esters” Journal of medical Chemistry, vol. 17, No. 2, Feb. 1974.
Kumar, N. et al:“Pharmacokinetics of 7 alpha-methyl-19-nortestosterone in men and cynomolgus monkeys” Chemical Abstracts, vol. 127, No. 18, Nov. 3, 1997.
Zhang, Y. et al: “Pharmacological studies of testosterone undecanoate, a new long-acting androgen preparation” Chemical Abstract, vol. 104 No. 9, Mar. 3, 1986.
Davidson, D. et al.: “Increasing testosterone undecanoate in eugonadal men” Chemical Abstract, vol. 107, No. 13, Sep. 28, 1987.
Bremner, William J. et al: (DN 134:80878, CAPLUS, abstract of Int. Congr. Ser. (2000), 1206 (Current Knowledge in Reproductive Medicine), 315-331).
Leysen Dirk
Van Der Voort Hendrikus Adrianus Antonius
Akzo Nobel N.V.
Dubberley F. Aaron
Milstead Mark
Qazi Sabiha
LandOfFree
Testosterone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Testosterone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Testosterone derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549040